Nov. 22, 2023 Price forecast | 2 weeks: -2.88% | 1 month: -1.08% | 3 months: 6.83%

KRON stock forecast

Our latest prediction for Kronos Bio Inc's stock price was made on the Nov. 22, 2023 when the stock price was at 1.24$.

In the short term (2weeks), KRON's stock price should underperform the market by -2.88%. During that period the price should oscillate between -12.10% and +5.49%.

In the medium term (3months), KRON's stock price should outperform the market by 6.83%. During that period the price should oscillate between -27.46% and +19.09%.

Create a solid portfolio with KRON

Add KRON to your portfolio and optimize it!

About Kronos Bio Inc

kronos bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. leveraging industry-leading research into high-throughput screening strategies for chemical modulators of transcription factors and other challenging targets in oncology, kronos utilizes its small molecule microarray (smm) platform and extensive know-how in biological assay development to pursue novel therapies against some of the most important and intractable targets in cancer research.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.08$ per share.

The book value per share is 1.54$

Kronos Bio Inc website

Three months stock forecastNov. 22, 2023


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -128M - -95M -2.08 - - 58M 1.54 - - -